BioGaia
116.7
SEK
-0.17 %
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-0.17%
+4.29%
+6.58%
+19.08%
-5.81%
+10.09%
+18.96%
+30.98%
+1,542.9%
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Read moreMarket cap
11.81B SEK
Turnover
22.17M SEK
Revenue
1.3B
EBIT %
34.18 %
P/E
32.24
Dividend yield-%
5.91 %
Financial calendar
12.2
2025
Annual report '24
7.5
2025
General meeting '25
7.5
2025
Interim report Q1'25
ShowingAll content types
BioGaia launches a new probiotic supplement, BioGaia® Gastrus® PURE ACTION, designed for people with sensitive digestive systems
BioGaia, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools